Business Wire

Inotrem Receives Funding From the Crohn’s & Colitis Foundation to Help Develop New Therapeutic Approaches in Inflammatory Bowel Disease (IBD)

Share

Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced today it received funding from the Crohn’s & Colitis Foundation’s IBD Ventures under a program to accelerate research and development that aim to improve the quality of life for patients with IBD. The funding will support the development of a new therapeutic approach in IBD focusing on the TREM-1 pathway.

The funding follows a R&D collaboration between Inotrem, and the Crohn’s & Colitis Foundation announced in April 2022. The R&D collaboration seeks to pave the way of a personalized medicine approach in IBD patients based on TREM-1. Under the terms of the agreement, Inotrem has access to data and bio-samples from Foundation’s IBD Plexus®, which is the largest IBD database in the US with data from over 25,000 patients. Lasting over 18 months, the project will be a cornerstone in the design of Inotrem’s first-in-human clinical study with INO-02.

There are today 10 million people worldwide suffering from IBD, and the need for new therapeutic options remains very strong. Approximately 30% of patients are unresponsive to existing therapies and even among the initial responders, in up to 10% the drugs lose efficacy over time. For a decade, Inotrem has been elucidating the biology of TREM-1 as a regulator of the immune response in both acute as well as chronic inflammatory diseases. TREM-1 is a potential important contributor to IBD pathophysiology and targeting this pathway may offer a new treatment option for IBD patients with immune dysregulation.

“We are grateful for the support of such a well-respected organization as The Crohn’s & Colitis Foundation. This funding will help us to expand our patented technology platform centered around the TREM-1 pathway and dedicated to developing new therapies for chronic inflammatory syndromes next to our existing modalities for acute diseases,” indicates Sven Zimmermann, CEO of Inotrem.

“Beyond the financial support, this is a strong recognition of Inotrem’s scientific leadership regarding the role of the TREM-1 pathway in inflammatory processes as well as our robust therapeutic approaches targeting that biological target,” says Marc Derive, Chief Scientific Officer and Cofounder of Inotrem.

About Inotrem

Inotrem S.A. is an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes. The company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Through its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with potential applications in a number of therapeutic indications such as septic shock and myocardial infarction. In parallel, Inotrem has also launched another program to develop a new therapeutic modality targeting chronic inflammatory diseases. The company was founded in 2013 by Dr Jean-Jacques Garaud, a former head of research and early development at the Roche Group, Prof. Sebastien Gibot and Dr Marc Derive. Inotrem is supported by leading European and North American investors. www.inotrem.com

About the Crohn’s & Colitis Foundation

The Crohn's & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn's disease and ulcerative colitis, and of improving the quality of life of the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process through investment in research initiatives, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public. For more information, visit crohnscolitisfoundation.org, call 888-694-8872, or email info@crohnscolitisfoundation.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contact for Inotrem
Anne REIN
Strategies & Image (S&I)
anne.rein@strategiesimage.com
+33 6 03 35 92 05

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KartRider: Drift Races Into Its Inaugural Season With Console Cross-play Date Reveal31.1.2023 19:01:00 CET | Press release

KartRider: Drift, Nexon’s completely free-to-play kart racing title, announced today its Season One date when consoles will join the online racing mix. Current Preseason PC and mobile racers on Steam, Nexon Launcher, Android, and iOS, will soon be able to compete head-to-head against Xbox and PlayStation players from all over the globe in thrilling, drift-fueled racing. Full cross-platform, cross-play will be available when Season One “New World” arrives on March 8. Season One also brings with it exciting new content – brand new tracks and race modes, a season-long theme, daily player rewards and events, plus many other improvements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005459/en/ Nexon's "KartRider: Drift" Announces March 8 Season One Arrival Date With New Gameplay Trailer. (Graphic: Business Wire) KartRider: Drift isn’t as simple as it may seem! The easy-to-learn, hard-to-master game offers distinct game mo

PPG achieves ISO 14001 certification of environmental management system31.1.2023 16:00:00 CET | Press release

PPG (NYSE: PPG) today announced that it has achieved International Organization for Standardization (ISO) 14001 certification for an environmental management system (EMS) at its Shannon, Ireland, operations. The company manufactures highly efficient, high-performing organic light-emitting diode (OLED) materials at the Universal Display Corporation (UDC) (Nasdaq: OLED) site. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005097/en/ PPG produces phosphorescent organic light-emitting diode (OLED) materials and technologies for Universal Display Corporation (UDC) that are up to four times more energy-efficient than conventional fluorescent OLED materials. UDC’s proprietary UniversalPHOLED® technology enhances the performance of consumer displays and lighting products by providing power savings that enable longer battery life in portable electronics and less energy consumption in larger display and lighting products. (Photo

Interactive Brokers Unveils New Feature to Help Clients Achieve Even Better Price Execution on US Options Trades31.1.2023 16:00:00 CET | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced the launch of its new IBUSOPT order destination. With the dramatic increase in retail options trading, Interactive Brokers has launched this new order destination to help its retail and institutional clients achieve better price execution on their options trades. IBUSOPT, a new order destination for US equity and index options, is designed to offer clients the opportunity to interact with IBKR SmartRoutedTM order flow and have their orders filled in between the National Best Bid/Offer (NBBO). The IBUSOPT destination helps traders execute options trades more efficiently and effectively and helps achieve better executions by providing traders with more control over their trades by supporting different order types. IBUSOPT orders will wait for an offsetting order from another IB customer and will not be shown to the market. The IBUSOPT-Pegged-to-Midpoint order type allows clients to peg their order

Hyosung America Launches New Brand Identity – Hyosung Innovue31.1.2023 16:00:00 CET | Press release

Hyosung America today announced “Hyosung Innovue,” a new brand identity. The change is the culmination of a year-long effort to reframe the company’s story of value as a human experience maker. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005393/en/ Hyosung Innovue -- improving life's day-to-day interactions for everyone. (Graphic: Business Wire) “Our company has a long history of harnessing its unique combination of a manufacturer’s soul with an innovator’s mindset to build a platform of ATM and cash-management solutions,” said Sanghwan Kweon, CEO of Hyosung America. “We are opening the aperture to extend our value creation deeper into financial services and retail while we bring our platform of integrated solutions to new verticals including hospitality and travel.” “It’s all about improving life’s day-to-day interactions for everyone,” said Brad Nolan, CMO of Hyosung America. “We elevate experience by bridging the

Botify Launches Botify Activation to Accelerate Speed to Market and Content Discoverability for the World’s Most Ambitious Brands31.1.2023 15:00:00 CET | Press release

Botify, a leading performance marketing platform for organic search, today announced the launch of Botify Activation to empower organizations to regain control of how search engines and consumers find products and services organically online. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005318/en/ A key suite within the Botify Platform, which already includes Botify Analytics and Botify Intelligence, Botify Activation connects insights about a website’s performance with making brands more discoverable online. By enabling scalable, automated site improvements and content discoverability, Botify Activation provides brands with the ability to expedite how search engines discover and interpret website pages—improving speed to market while also boosting efficiency across teams. Specifically, Botify Activation is comprised of the following solutions: SpeedWorkers: Serves fully-rendered pages to search engines, ensuring mor